Liver transplantation during global COVID-19 pandemic

Mostafa Alfishawy; Nso Nso; Mahmoud Nassar; Jonathan Ariyaratnam; Sakil Bhuiyan; Raheel S Siddiqui; Matthew Li; Howard Chung; Amira Al Balakosy; Ahmed Alqassieh; Tibor Fülöp; Vincent Rizzo; Ahmed Daoud; Karim M Soliman

doi:10.12998/wjcc.v9.i23.6608

Liver transplantation during global COVID-19 pandemic

World J Clin Cases. 2021 Aug 16;9(23):6608-6623. doi: 10.12998/wjcc.v9.i23.6608.

Authors

Affiliations

¹ Infectious Diseases, Infectious Diseases Consultants and Academic Researchers of Egypt IDCARE, Cairo 0000, Egypt.
² Department of Medicine, Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Queens), New York, NY 11373, United States.
³ Clinical pharmacy department, Icahn School of Medicine at Mount Sinai (NYC Health and Hospitals: Queens), New York, NY 11373, United States.
⁴ Tropical Medicine Department, Ain Shams University, Cairo 11517, Egypt.
⁵ Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, United States.
⁶ Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, United States.
⁷ Department of Medicine, Kasr Alainy Medical School, Cairo University, Cairo 11562, Egypt. ahmed.daoud84@yahoo.com.

Abstract

The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory disease respiratory syndrome coronavirus-2 has significantly impacted the health care systems globally. Liver transplantation (LT) has faced an unequivocal challenge during this unprecedented time. This targeted review aims to cover most of the clinical issues, challenges and concerns about LT during the COVID-19 pandemic and discuss the most updated literature on this rapidly emerging subject.

Keywords: COVID-19; Calcineurin inhibitors; Cytokine; Distributive justice; End-stage liver disease; Immunosuppression; Liver transplantation; Mortality.

Publication types

Review